Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels.
- DOI
- 10.1002/npr2.12190
- Published
- 2021 Sep
- Container
- Neuropsychopharmacology reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/npr2.12190,
title = {Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels.},
author = {Tasaki M and Yasui-Furukori N and Yokoyama S and Shinozaki M and Sugawara N and Shimoda K},
year = {2021},
journal = {Neuropsychopharmacology reports},
doi = {10.1002/npr2.12190},
url = {https://doi.org/10.1002/npr2.12190}
}RIS
TY - JOUR TI - Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels. AU - Tasaki M AU - Yasui-Furukori N AU - Yokoyama S AU - Shinozaki M AU - Sugawara N AU - Shimoda K PY - 2021 JO - Neuropsychopharmacology reports DO - 10.1002/npr2.12190 UR - https://doi.org/10.1002/npr2.12190 ER -
APA
M, T., N, Y., S, Y., M, S., N, S., & K, S. (2021). Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels.. Neuropsychopharmacology reports. https://doi.org/10.1002/npr2.12190
Source records
- pubmed · retrieved 2026-09-27T00:30:30.753Z
- europe-pmc · retrieved 2026-09-27T00:30:30.767Z
- doaj · retrieved 2026-09-27T00:30:30.764Z